Lanlan Shen
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
- Genomics and Chromatin Dynamics
Papers in
-
- Epigenetics and DNA Methylation 63
- Cancer-related gene regulation 23
- RNA modifications and cancer 22
-
- Phase-change materials and chalcogenides 11
- Co-authors
- Jean‐Pierre J. Issa (58 shared papers)Yutaka Kondo (20 shared papers)Saira Ahmed (14 shared papers)Jaroslav Jelı́nek (19 shared papers)Stanley R. Hamilton (10 shared papers)Hagop M. Kantarjian (9 shared papers)Yi Guo (9 shared papers)Robert A. Waterland (10 shared papers)
- Journals
- Cancer Research (8 papers)PLoS ONE (7 papers)Blood (5 papers)Proceedings of the National Academy of Sciences (4 papers)PLoS Genetics (4 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Lanlan Shen
127 papers receiving 11.0k citations
Lanlan Shen's Hit Papers
Peers
Comparison fields: 5 of 156
- Hematology 1.5k
- Molecular Biology 7.3k
- Cancer Research 1.4k
- Pathology and Forensic Medicine 929
- Oncology 1.4k
Countries citing papers authored by Lanlan Shen
This map shows the geographic impact of Lanlan Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lanlan Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lanlan Shen more than expected).
Fields of papers citing papers by Lanlan Shen
This network shows the impact of papers produced by Lanlan Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lanlan Shen. The network helps show where Lanlan Shen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lanlan Shen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 134 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Decitabine improves patient outcomes in myelodysplastic syndromes Hit paper breakdown → | 2006 | 1200 |
| 2 | Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation Hit paper breakdown → | 2008 | 500 |
| 3 | 2010 | 451 | |
| 4 | 2007 | 451 | |
| 5 | 2003 | 428 | |
| 6 | 2005 | 400 | |
| 7 | 2010 | 360 | |
| 8 | 2007 | 305 | |
| 9 | 2002 | 300 | |
| 10 | 2009 | 279 | |
| 11 | 2006 | 228 | |
| 12 | 2006 | 224 | |
| 13 | 2002 | 223 | |
| 14 | 2007 | 223 | |
| 15 | 2008 | 202 | |
| 16 | 2007 | 189 | |
| 17 | 2007 | 173 | |
| 18 | 2001 | 169 | |
| 19 | 2007 | 157 | |
| 20 | Aberrant methylation of the Cyclooxygenase 2 CpG island in colorectal tumors. | 2000 | 154 |
About Lanlan Shen
Lanlan Shen is a scholar working on Molecular Biology, Materials Chemistry, Electrical and Electronic Engineering, Oncology and Genetics, having authored 134 papers that have together received 11.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (63 papers), Cancer-related gene regulation (23 papers), RNA modifications and cancer (22 papers), Phase-change materials and chalcogenides (11 papers), Chalcogenide Semiconductor Thin Films (11 papers), Acute Myeloid Leukemia Research (9 papers), Genetic factors in colorectal cancer (9 papers) and Conducting polymers and applications (8 papers). The work is most often cited by research in Hematology (1.5k citations), Molecular Biology (7.3k citations), Cancer Research (1.4k citations), Pathology and Forensic Medicine (929 citations) and Oncology (1.4k citations). Lanlan Shen has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Jean‐Pierre J. Issa, Yutaka Kondo, Saira Ahmed, Jaroslav Jelı́nek, Stanley R. Hamilton, Hagop M. Kantarjian, Yi Guo, Robert A. Waterland, Marcos R. Estecio and Jiexin Zhang. Their work appears in journals such as Cancer Research, PLoS ONE, Blood, Proceedings of the National Academy of Sciences and PLoS Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.